Your browser doesn't support javascript.
loading
Global implementation of the world health organization's International Classification of Diseases (ICD)-11: The allergic and hypersensitivity conditions model.
Tanno, Luciana Kase; Chalmers, Robert; Jacob, Robert; Kostanjsek, Nenad; Bierrenbach, Ana Luiza; Martin, Bryan; Molinari, Nicolas; Annesi-Maesano, Isabella; Papadopoulos, Nikolaos G; Sanchez-Borges, Mario; Rosenwasser, Lanny J; Ansontegui, Ignacio; Ebisawa, Motohiro; Sisul, Juan Carlos; Jares, Edgardo; Gomez, Maximiliano; Agache, Ioana; Muraro, Antonella; Wong, Gary W K; Thien, Francis; Pawankar, Ruby; Mahr, Todd A; Sublett, James L; Lang, David M; Casale, Thomas; Demoly, Pascal.
Afiliação
  • Tanno LK; Hospital Sírio-Libanês, São Paulo, Brazil.
  • Chalmers R; University Hospital of Montpellier, Montpellier, France.
  • Jacob R; INSERM UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Université, Paris, France.
  • Kostanjsek N; WHO Collaborating Centre on Scientific Classification Support, Montpellier, France.
  • Bierrenbach AL; ICD-11 Medical and Scientific Advisory Committee, WHO, Geneva, Switzerland.
  • Martin B; ICD-11 Medical and Scientific Advisory Committee, WHO, Geneva, Switzerland.
  • Molinari N; Centre for Dermatology, University of Manchester, Manchester, UK.
  • Annesi-Maesano I; Classifications, Terminologies and Standards, World Health Organization, Geneva, Switzerland.
  • Papadopoulos NG; Classifications, Terminologies and Standards, World Health Organization, Geneva, Switzerland.
  • Sanchez-Borges M; Hospital Sírio-Libanês, São Paulo, Brazil.
  • Rosenwasser LJ; Sanas Epidemiology and Research, São Paulo, Brazil.
  • Ansontegui I; Teaching Research Institute (IEP), Hospital Sírio Libanês, São Paulo, Brazil.
  • Ebisawa M; Medicine and Pediatrics, The Ohio State University in Columbus, Columbus, OH, USA.
  • Sisul JC; IMAG UMR 5149, DIM CHRU de Montpellier, France.
  • Jares E; INSERM UMR-S 1136, IPLESP, Equipe EPAR, Sorbonne Université, Paris, France.
  • Gomez M; Centre for Paediatrics and Child Health, Institute of Human Development, University of Manchester, Manchester, UK.
  • Agache I; Department of Allergy, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
  • Muraro A; Allergy and Clinical Immunology Department, Centro Medico Docente La Trinidad, Caracas, Venezuela.
  • Wong GWK; Division of Immunology Research, Department of Pediatrics, Children's Mercy Hospitals & Clinics, Kansas City, MO, USA.
  • Thien F; Department of Allergy and Immunology, Hospital Quirónsalud Bizkaia Erandio, Bilbao, Spain.
  • Pawankar R; Clinical Research Center for Allergy and Rheumatology, Sagamihara National Hospital, Sagamihara, Japan.
  • Mahr TA; Latinalerican Society of Allergy, Asthma and Immunology, Villarica, Paraguay.
  • Sublett JL; American College of Allergy, Asthma and Immunology, Arlington Heights, IL, USA.
  • Lang DM; LIBRA Foundation and CMP SA Buenos Aires, Buenos Aires, Argentina.
  • Casale T; Research & Education, Fundación Ayre, Allergy & Asthma Unit, Hospital San Bernardo, Catholic University of Salta, Salta, Argentina.
  • Demoly P; Transylvania University, Brasov, Romania.
Allergy ; 75(9): 2206-2218, 2020 09.
Article em En | MEDLINE | ID: mdl-32578235
ABSTRACT
The International Classification of Diseases (ICD) provides a common language for use worldwide as a diagnostic and classification tool for epidemiology, clinical purposes and health management. Since its first edition, the ICD has maintained a framework distributing conditions according to topography, with the result that some complex conditions, such as allergies and hypersensitivity disorders (A/H) including anaphylaxis, have been poorly represented. The change in hierarchy in ICD-11 permitted the construction of the pioneer section addressed to A/H, which may result in more accurate mortality and morbidity statistics, including more accurate accounting for mortality due to anaphylaxis, strengthen classification, terminology and definitions. The ICD-11 was presented and adopted by the 72nd World Health Assembly in May 2019, and the implementation is ongoing worldwide. We here present the outcomes from an online survey undertaken to reach out the allergy community worldwide in order to peer review the terminology, classification and definitions of A/H introduced into ICD-11 and to support their global implementation. Data are presented here for 406 respondents from 74 countries. All of the subsections of the new A/H section of the ICD-11 had been considered with good accuracy by the majority of respondents. We believe that, in addition to help during the implementation phase, all the comments provided will help to improve the A/H classification and to increase awareness by different disciplines of what actions are needed to ensure more accurate epidemiological data and better clinical management of A/H patients.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Hipersensibilidade a Medicamentos / Anafilaxia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndrome de Hipersensibilidade a Medicamentos / Anafilaxia Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article